Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
Article
PubMed
Google Scholar
DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62.
Article
PubMed
Google Scholar
Shah R, Rosso K, Nathanson SD. Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol. 2014;5(3):283–98.
Article
PubMed
PubMed Central
Google Scholar
Hosford SR, Miller TW. Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways. Pharmgenomics Pers Med. 2014;7:203–15.
CAS
PubMed
PubMed Central
Google Scholar
Yamamoto-Ibusuki M, Arnedos M, Andre F. Targeted therapies for ER+/HER2-metastatic breast cancer. BMC Med. 2015;doi: https://doi.org/10.1186/s12916-015-0369-5.
Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, et al. Phase II study of receptor enhanced chemosensitivity using recombinant humanized anti-p185HER2/neumonoclonal antibody plus cisplatin in patients with HER2/neu overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol. 1998;16(8):2659–71.
Article
CAS
PubMed
Google Scholar
Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007;13(8):2329–34.
Article
CAS
PubMed
Google Scholar
Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's surveillance, epidemiology, and end results database. Cancer. 2007;110(4):876–84.
Article
PubMed
Google Scholar
Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002;82(11):1336–45.
CAS
Google Scholar
Atawodi SE, Atawodi JC. Azadirachta indica (neem): a plant of multiple biological and pharmacological activities. Phytochem Rev. 2009;8(3):601–20.
Article
CAS
Google Scholar
Tan QG, Luo XD. Meliaceous limonoids: chemistry and biological activities. Chem Rev. 2011;111(11):7437–522.
Article
CAS
PubMed
Google Scholar
Haldar S, Phapale PB, Koleta SP, Thulasiram HV. Expedient preparative isolation, quantification and characterization of limonoids from neem fruits. Anal Methods. 2013;5:5386–91.
Article
CAS
Google Scholar
Babykutty S, Priya PS, Nandini RJ, Kumar MA, Nair MS, Srinivas P, et al. Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells. Mol Carcinog. 2012;51(6):475–90.
Article
CAS
PubMed
Google Scholar
Priyadarsini RV, Murugan RS, Sripriya P, Karunagaran D, Nagini S. The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells. Free Radic Res. 2010;44(6):624–34.
Article
CAS
PubMed
Google Scholar
Brandt GE, Schmidt MD, Prisinzano TE, Blagg BS. Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships. J Med Chem. 2008;51(20):6495–502.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nanduri S, Thunuguntla SS, Nyavanandi VK, Kasu S, Kumar PM, Ram PM, et al. Biological investigation and structure-activity relationship studies on azadirone from Azadirachta Indica a. Juss Bioorg Med Chem Lett. 2003;13(22):4111–5.
Article
CAS
PubMed
Google Scholar
Kikuchi T, Ishii K, Noto T, Takahashi A, Tabata K, Suzuki T, et al. Cytotoxic and apoptosis-inducing activities of limonoids from the seeds of azadirachta indica (neem). J Nat Prod. 2011;74(4):866–70.
Article
CAS
PubMed
Google Scholar
Govindachari TR, Suresh G, Gopalakrishnan G, Wesley SD. Insect antifeedant and growth regulating activities of neem seed oil-the role of major tetranortriterpenoids. J Appl Entomol. 2000;124(7–8):287–91.
Article
CAS
Google Scholar
Haldar S, Mulani FA, Aarthy T, Dandekar DS, Thulasiram HV. Expedient preparative isolation and tandem mass spectrometric characterization of C-Seco triterpenoids from neem oil. J Chromatogr A. 2014;1366:1–14.
Article
CAS
PubMed
Google Scholar
Ko CH, Shen SC, Hsu CS, Chen YC. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem Pharmacol. 2005;69(6):913–27.
Article
CAS
PubMed
Google Scholar
Ko SK, Kim SK, Share A, Lynch VM, Park J, Namkung W, et al. Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells. Nat Chem. 2014;6(10):885–92.
Article
CAS
PubMed
Google Scholar
Katoh I, Tomimori Y, Ikawa Y, Kurata S. Dimerization and processing of proCaspase-9 by redox stress in mitochondria. J Biol Chem. 2004;279(15):15515–23.
Article
CAS
PubMed
Google Scholar
McDonnell MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A. Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells. Cell Death Differ. 2003;10(9):1005–15.
Article
CAS
PubMed
Google Scholar
Kumar S, Patil HS, Sharma P, Kumar D, Dasari S, Puranik VG, et al. Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3kinase/Akt signaling pathway. Curr Mol Med 2012;12(8):952–66.
Article
CAS
PubMed
Google Scholar
Ghosh S, Adhikary A, Chakraborty S, Bhattacharjee P, Mazumder M, Putatunda S, et al. Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine. J Biol Chem. 2015;290(7):3936–49.
Article
CAS
PubMed
Google Scholar
Gavilan E, Giraldez S, Sanchez-Aguayo I, Romero F, Ruano D, Daza P. Breast cancer cell line MCF7 escapes from G1/S arrest induced by proteasome inhibition through a GSK-3β dependent mechanism. Sci Rep. 2015;5:10027.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thakur R, Anand R, Tiwari S, Singh AP, Tiwary BN, Shankar J. Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells? Front Microbiol. 2015;6:429.
Article
PubMed
PubMed Central
Google Scholar
Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17(3):590–603.
Article
CAS
PubMed
Google Scholar
Hennessy BT, Smith L, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005;4(12):988–1004.
Article
CAS
PubMed
Google Scholar
Will M, Qin AC, Toy W, Yao Z, Rodrik-Outmezguine V, Schneider C, et al. Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling. Cancer Discov. 2014;4(3):334–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis. 2010;31(2):192–200.
Article
CAS
PubMed
Google Scholar
Xiao D, Powolny AA, Singh SV. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem. 2008;283(44):30151–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar V, Behera R, Lohite K, Karnik S, Kundu GC. p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression. Cancer Res. 2010;70(24):10381–91.
Article
CAS
PubMed
Google Scholar
Mishra R, Thorat D, Soundararajan G, Pradhan SJ, Chakraborty G, Lohite K, et al. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. Oncogene. 2015;34(12):1584–95.
Article
CAS
PubMed
Google Scholar
Hideshima T, Catley L, Yasui H, Ishitsuka K, Raje N, Mitsiades C, et al. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood. 2006;107(10):4053–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar S, Sharma P, Kumar D, Chakraborty G, Gorain M, Kundu GC. Functional characterization of stromal osteopontin in melanoma progression and metastasis. PLoS One. 2013;8(7):e69116.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jain S, Chakraborty G, Kundu GC. The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Cancer Res. 2006;66(13):6638–48.
Article
CAS
PubMed
Google Scholar
Ahmed M, Kundu GC. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Mol Cancer. 2010;9:101.
Article
PubMed
PubMed Central
Google Scholar
Sharma P, Kumar S, Kundu GC. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. Mol Cancer. 2010;9:178.
Article
PubMed
PubMed Central
Google Scholar
Kumar D, Kumar S, Gorain M, Tomar D, Patil HS, Radharani NN, et al. Notch1-MAPK signaling axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis. J Invest Dermatol. 2016;136(12):2462–74.
Article
CAS
PubMed
Google Scholar
Sharpe JC, Arnoult D, Youle RJ. Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta. 2004;1644(2–3):107–13.
Article
CAS
PubMed
Google Scholar
Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479–89.
Article
CAS
PubMed
Google Scholar
Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brachbiel MW, Kasumi F, et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res. 2002;62(2):560–6.
CAS
PubMed
Google Scholar
Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 2008;68(1):152–61.
Article
CAS
PubMed
Google Scholar
Ahmed M, Behera R, Chakraborty G, Jain S, Kumar V, Sharma P, et al. Osteopontin: a potentially important therapeutic target in cancer. Expert Opin Ther Targets. 2011;15(9):1113–26.
Article
CAS
PubMed
Google Scholar
Rangaswami H, Kundu GC. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep. 2007;18(4):909–15.
CAS
PubMed
Google Scholar
Eiro N, Fernandez-Garci B, González LO, Vizoso FJ. Clinical relevance of matrix metalloproteases and their inhibitors in breast cancer. J Carcinog Mutagen. 2013;S13
Sliva D, Rizzo MT, English D. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem. 2002;277(5):3150–7.
Article
CAS
PubMed
Google Scholar
Kumar D, Gorain M, Kundu G, Kundu GC. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma. Mol Cancer. 2017;16(1):7.
Article
PubMed
PubMed Central
Google Scholar
Koul O, Multani JS, Goomber S, Daniewski WM, Berlozecki S. Activity of some nonazadirachtin limonoids from Azadirachta Indica against lepidopteran larvae. Aust J Entomol. 2004;43(2):189–95.
Article
Google Scholar
Srivastava P, Yadav N, Lella R, Schneider A, Jones A, Marlowe T, et al. Neem oil limonoids induces p53-independent apoptosis and autophagy. Carcinogenesis. 2012;33(11):2199–207.
Article
CAS
PubMed
PubMed Central
Google Scholar
Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ∆Ψ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997;411(1):77–82.
Article
CAS
PubMed
Google Scholar
Carmen JC, Hardi L, Sinai AP. Toxoplasma gondii inhibits ultraviolet light-induced apoptosis through multiple interactions with the mitochondrion-dependent programmed cell death pathway. Cell Microbiol. 2006;8(2):301–15.
Article
CAS
PubMed
Google Scholar
Varbiro G, Veres B, Gallyas FJr, Sumegi B. Direct effect of taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med. 2001;31(4):548–58.
Article
CAS
PubMed
Google Scholar
Perkins CL, Fang G, Kim CN, Bhalla KN. The role of Apaf-1, Caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 2000;60(6):1645–53.
CAS
PubMed
Google Scholar
Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature. 2001;410(6828):549–54.
Article
CAS
PubMed
Google Scholar
Kale S, Raja R, Thorat D, Soundararajan G, Patil TV, Kundu GC. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Oncogene. 2014;33(18):2295–306.
Article
CAS
PubMed
Google Scholar
Raja R, Kale S, Thorat D, Soundararajan G, Lohite K, Mane A, et al. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Oncogene. 2014;33(16):2053–64.
Article
CAS
PubMed
Google Scholar
Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, et al. Osteopontin as a therapeutic target for cancer. Expert Opin Ther Targets. 2014;18(8):883–95.
Article
CAS
PubMed
Google Scholar
Miyazawa Y, Uekita T, Ito Y, Seiki M, Yamaguchi H, Sakai R. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells. Mol Cancer Res. 2013;11(6):628–37.
Article
CAS
PubMed
Google Scholar
Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer. 2013;49(18):3914–23.
Article
PubMed
Google Scholar
Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, et al. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell. 2007;12(4):395–402.
Article
CAS
PubMed
Google Scholar